AbstractA 67-year-old Han Chinese man had been suffering from Parkinson's disease (PD) for 3 years. He received slow-release Madopar 250 mg and Madopar 375 mg per day for his PD. He suffered an L3 compression fracture in an accident and was hospitalized for surgery because of severe back pain. He was referred to a psychiatrist because of severe depression. Duloxetine (30 mg twice per day, without titration) was prescribed for both antidepressant and analgesic effects. This regimen was continued for 7 months with no deterioration in cognitive function, and no worsening of PD was observed in his monthly follow-up. Duloxetine, which is a serotonin and noradrenaline reuptake inhibitor, may have the same antidepressant effect as tricyclic antide...
A recent study to investigate the safety and efficacy of serotonin reuptake inhibitors suggests that...
Selective serotonin reuptake inhibitors have been used in the treatment of depression in patients wi...
Depression occurs in around 35% of patients with Parkinson disease (PD) and is often persistent. Sym...
AbstractA 67-year-old Han Chinese man had been suffering from Parkinson's disease (PD) for 3 years. ...
Objective: Depression is a comorbidity affecting quality of life (QoL) in patients with Parkinson's ...
© 2020 Shahrul Azmin Bin Md. RaniPain in Parkinsons disease is common and poorly managed. The body o...
The prevalence of depression in Parkinson's disease (PD) amounts to as much as 90%. The paper descri...
Depression is a frequent non-motor symptom of Parkinson's disease (PD), and may even precede the ons...
The prevalence of non-motor symptoms in Parkinson's disease (PD) is high. Depression varies from 20 ...
Depressive disorders as well as depressive symptoms are common in Parkinson's disease (PD) and an im...
Depression is one of the most common non-motor manifestations of Parkinson's disease (PD), which lar...
Depression is common in Parkinson’s disease (PD), and a recent analysis of existing research estimat...
International audienceDepression is one of the most common psychiatric disturbances in Parkinson's d...
Objectives We present six case reports of patients with Parkinson's disease (PD) at various stages, ...
Major Depressive Disorder (MDD) is among the most frequent comorbidities occurring in the course of ...
A recent study to investigate the safety and efficacy of serotonin reuptake inhibitors suggests that...
Selective serotonin reuptake inhibitors have been used in the treatment of depression in patients wi...
Depression occurs in around 35% of patients with Parkinson disease (PD) and is often persistent. Sym...
AbstractA 67-year-old Han Chinese man had been suffering from Parkinson's disease (PD) for 3 years. ...
Objective: Depression is a comorbidity affecting quality of life (QoL) in patients with Parkinson's ...
© 2020 Shahrul Azmin Bin Md. RaniPain in Parkinsons disease is common and poorly managed. The body o...
The prevalence of depression in Parkinson's disease (PD) amounts to as much as 90%. The paper descri...
Depression is a frequent non-motor symptom of Parkinson's disease (PD), and may even precede the ons...
The prevalence of non-motor symptoms in Parkinson's disease (PD) is high. Depression varies from 20 ...
Depressive disorders as well as depressive symptoms are common in Parkinson's disease (PD) and an im...
Depression is one of the most common non-motor manifestations of Parkinson's disease (PD), which lar...
Depression is common in Parkinson’s disease (PD), and a recent analysis of existing research estimat...
International audienceDepression is one of the most common psychiatric disturbances in Parkinson's d...
Objectives We present six case reports of patients with Parkinson's disease (PD) at various stages, ...
Major Depressive Disorder (MDD) is among the most frequent comorbidities occurring in the course of ...
A recent study to investigate the safety and efficacy of serotonin reuptake inhibitors suggests that...
Selective serotonin reuptake inhibitors have been used in the treatment of depression in patients wi...
Depression occurs in around 35% of patients with Parkinson disease (PD) and is often persistent. Sym...